Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

AdventHealth Translational Research Institute · with BPGbio · NCT04807868

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
1250
US sites recruiting
1
Study start
April 22, 2021
Record last updated
March 13, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressive interventions for those at highest risk for non-alcoholic fatty liver disease (NAFLD). To achieve this, we will generate a biobank of liver tissue collected during standard of care liver biopsies. Paired blood/urine samples, FibroScan and relevant data will also be collected.

Being studied: Standard of care liver biopsy; Fibroscan; Biospecimen Collection

Conditions: Non-Alcoholic Fatty Liver Disease

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Females and Males ≥ 18 years of age.
  • Understands the procedures and agrees to participate by giving written informed consent.

Biopsy Group Only

  • Scheduled for standard of care liver biopsy for any reason.

Non-Biopsy Group Only

  • BMI ≥ 25, with or without type 2 diabetes, without any level of NAFLD based on: (1) Recent medical history (within 6 months of screening visit). (2) Data collected from participation in a prior research study where they consented to be re-contacted for future studies.

Exclusion Criteria

  • Women who are pregnant when referred for a liver biopsy will be excluded.
  • Presence of any condition that, in the opinion of the Investigator, compromises participant safety or data integrity or the participant's ability to complete the study.

Otherwise, all eligible patients who consent will be included in AVAIL. If participants in the non-biopsy group are found to have NAFLD based on the FibroScan done for this study, then they will be informed of this and advised to follow up with their physician. Their data will still be part of the registry and analyzed with the biopsy group that is found to have NAFLD.

Recruiting US locations

  • AdventHealth Translational Research Institute

    Orlando, FL 32804

    Site contact: Recruitment Department · 407-303-7100 · Fh.tri.recruitment@adventhealth.com

Study contacts (from the official record)

  • Recruitment Department · 407-303-7100 · Fh.tri.recruitment@adventhealth.com
All nutrition & metabolism studies in Florida →
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease… (NCT04807868) | Bored Studies